November 24, 2016 - By Marguerite Chambers · 0 Comments
The stock of Alere Incorporated (NYSE:ALR) registered an increase of 3.72% in short interest. ALR’s total short interest was 2.35M shares in November as published by FINRA. Its up 3.72% from 2.27 million shares, reported previously. With 482,100 shares average volume, it will take short sellers 5 days to cover their ALR’s short positions. The short interest to Alere Incorporated’s float is 2.73%. The stock increased 0.64% or $0.25 on November 23, hitting $39.04. About 313,760 shares traded hands. Alere Inc (NYSE:ALR) has declined 9.96% since April 22, 2016 and is downtrending. It has underperformed by 15.37% the S&P500.
Alere Inc. is a provider of health information through diagnostic tests. The company has a market cap of $3.35 billion. The Company’s divisions include professional diagnostics, consumer diagnostics, and corporate and other. It currently has negative earnings. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.
Insitutional Activity: The institutional sentiment decreased to 0.88 in 2016 Q2. Its down 0.01, from 0.89 in 2016Q1. The ratio dropped, as 28 funds sold all Alere Inc shares owned while 79 reduced positions. 24 funds bought stakes while 71 increased positions. They now own 73.65 million shares or 1.98% less from 75.14 million shares in 2016Q1.
State Of Alaska Department Of Revenue accumulated 3,016 shares or 0.01% of the stock. Moreover, Bancorporation Of America Corporation De has 0% invested in Alere Inc (NYSE:ALR) for 50,160 shares. Moreover, Twin has 10.29% invested in Alere Inc (NYSE:ALR) for 1.37 million shares. Moreover, Advisory Svcs Networks Ltd Com has 0% invested in Alere Inc (NYSE:ALR) for 402 shares. Alpine Associates Management accumulated 2.25M shares or 3.34% of the stock. Panagora Asset Mngmt holds 4,800 shares or 0% of its portfolio. Glg Prtnrs Ltd Partnership accumulated 0.63% or 507,068 shares. Addison accumulated 2.02% or 53,763 shares. Bankshares Of Mellon last reported 403,951 shares in the company. Bancorp Of Montreal Can holds 0% or 600 shares in its portfolio. Envestnet Asset Mngmt accumulated 0% or 3,290 shares. Halcyon Mngmt Ptnrs L P, a New York-based fund reported 27,558 shares. Cubist Systematic Strategies Lc has invested 0.02% of its portfolio in Alere Inc (NYSE:ALR). First New York Limited Liability Co Ny has 0% invested in the company for 6,000 shares. Winfield has invested 0% of its portfolio in Alere Inc (NYSE:ALR).
Out of 7 analysts covering Alere (NYSE:ALR), 4 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 57% are positive. Alere has been the topic of 14 analyst reports since August 4, 2015 according to StockzIntelligence Inc. The stock of Alere Inc (NYSE:ALR) earned “Hold” rating by Canaccord Genuity on Tuesday, February 2. On Thursday, April 28 the stock rating was upgraded by Leerink Swann to “Outperform”. The stock has “Buy” rating given by BTIG Research on Tuesday, August 4. On Monday, November 7 the stock rating was maintained by Canaccord Genuity with “Buy”. BTIG Research downgraded the stock to “Neutral” rating in Tuesday, March 15 report. On Thursday, November 5 the stock rating was maintained by Canaccord Genuity with “Buy”. The stock of Alere Inc (NYSE:ALR) has “Buy” rating given on Thursday, September 29 by Canaccord Genuity. Craig Hallum downgraded Alere Inc (NYSE:ALR) rating on Tuesday, February 2. Craig Hallum has “Hold” rating and $56 price target. The firm has “Hold” rating by TheStreet given on Friday, August 14. As per Thursday, November 5, the company rating was maintained by Wedbush.
Alere Inc., incorporated on May 11, 2001, is a well-known provider of health information through diagnostic tests. The Company’s divisions include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing activities related to its role as the exclusive maker of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G).
More notable recent Alere Inc (NYSE:ALR) news were published by: Businesswire.com which released: “Robbins Arroyo LLP: Alere Inc. (ALR) Misled Shareholders According to a …” on November 18, 2016, also Fool.com with their article: “Alere Inc. Has Been Left for Dead, With Its Shares Down 13%” published on November 04, 2016, Prnewswire.com published: “ALR LOSS ALERT: Rosen Law Firm Reminds Alere Inc. Investors of Important …” on November 22, 2016. More interesting news about Alere Inc (NYSE:ALR) were released by: Fool.com and their article: “Why Alere Inc. Climbed 21% Today” published on July 28, 2016 as well as Prnewswire.com‘s news article titled: “SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation …” with publication date: November 07, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Marguerite Chambers